Veracyte Inc (VCYT NASDAQ) stock market data APIs
$40.6509
0.35(0.9%)
as of May 7, 2026
Try our APIs with
free plan!
Veracyte Inc Financial Data Overview
Price chart is built with
Anychart
Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Genomic Classifiers for prostate cancer diagnosis; Decipher Bladder Genomic Classifier for bladder cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; and Percepta Nasal Swab Test for lung cancer diagnosis. It also provides the nCounter analysis system services. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.
Prev. Close
40.6509
Open
40.9976
High
41.8142
Low
40.468
52 wk Range
22.61-50.71
Market Cap
3 252 M
P/E Ratio
37.7407
Shares Outstanding
79 792 K
Revenue
542 M
EPS
0.52
Beta
1.885
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Veracyte Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Veracyte Inc data using free add-ons & libraries
Get Veracyte Inc Fundamental Data
Veracyte Inc Fundamental data includes:
- Net Revenue: 542 M
- EBITDA: 102 M
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-05-12
- EPS/Forecast: 0.3293
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Veracyte Inc News
New
Why Veracyte Stock Is Skyrocketing Higher This Week
Key Points Veracyte grew revenue by 21% in Q1 and saw earnings per share quadruple from last year, as margins ballooned. Sales for the company's main prostate and thyroid cancer-detecting tests conti...
Veracyte (VCYT) Beats Q1 Earnings and Revenue Estimates
Veracyte (VCYT) came out with quarterly earnings of $0.52 per share, beating the Zacks Consensus Estimate of $0.34 per share. This compares to earnings of $0.31 per share a year ago. These figures are...
Veracyte, Inc. Q1 2026 Earnings Call Summary
Veracyte, Inc. Q1 2026 Earnings Call Summary - Moby Strategic Execution and Performance Drivers Performance was driven by a multi-year transformation into a scalable, diversified company, achieving ...
Veracyte (VCYT) Q1 2026 Earnings Transcript
Image source: The Motley Fool. Date May 5, 2026 Call participants Chief Executive Officer — Marc Stapley Chief Financial Officer — Rebecca Chambers Chief Commercial Officer — John Leite Chie...
Get Veracyte Inc fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
